Alliancebernstein L.P. Theravance Biopharma, Inc. Transaction History

Alliancebernstein L.P.

$300 Billion
Q3 2025

A detailed history of Alliancebernstein L.P. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 70,080 shares of TBPH stock, worth $1.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,080

Previous 70,080 -0.0%

Holding current value

$1.22 Million

Previous $772,000 32.51%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.32 - $11.25 $27,456 - $37,125	-3,300 Reduced 4.5%	70,080 $772,000
Q1 2025 May 15, 2025	SELL	$8.44 - $10.47 $31,860 - $39,524	-3,775 Reduced 4.89%	73,380 $655,000
Q4 2024 Feb 12, 2025	SELL	$7.93 - $10.08 $13,481 - $17,136	-1,700 Reduced 2.16%	77,155 $726,000
Q2 2024 Aug 14, 2024	BUY	$8.29 - $9.92 $51,563 - $61,702	6,220 Added 8.56%	78,855 $668,000
Q1 2024 May 14, 2024	SELL	$8.22 - $11.59 $41,922 - $59,109	-5,100 Reduced 6.56%	72,635 $651,000
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $1,666 - $2,592	200 Added 0.26%	77,735 $743,000
Q4 2021 Feb 14, 2022	BUY	$7.42 - $11.05 $50,456 - $75,140	6,800 Added 9.61%	77,535 $857,000
Q1 2021 May 06, 2021	SELL	$16.57 - $21.08 $99,420 - $126,479	-6,000 Reduced 7.82%	70,735 $1.44 Million
Q3 2020 Nov 12, 2020	SELL	$14.79 - $22.49 $19,227 - $29,236	-1,300 Reduced 1.67%	76,735 $1.14 Million
Q2 2020 Aug 13, 2020	BUY	$20.64 - $30.69 $278,640 - $414,315	13,500 Added 20.92%	78,035 $1.64 Million
Q1 2020 May 14, 2020	BUY	$17.84 - $31.21 $5,352 - $9,363	300 Added 0.47%	64,535 $1.49 Million
Q4 2019 Feb 18, 2020	BUY	$16.12 - $25.89 $20,956 - $33,657	1,300 Added 2.07%	64,235 $1.66 Million
Q4 2018 Feb 13, 2019	SELL	$22.52 - $35.07 $15,764 - $24,549	-700 Reduced 1.1%	62,935 $1.61 Million
Q3 2018 Nov 08, 2018	BUY	$22.83 - $32.67 $41,094 - $58,806	1,800 Added 2.91%	63,635 $2.08 Million
Q2 2018 Aug 13, 2018	BUY	$22.06 - $25.52 $48,532 - $56,144	2,200 Added 3.69%	61,835 $1.4 Million
Q1 2018 May 14, 2018	SELL	$23.37 - $29.71 $37,392 - $47,536	-1,600 Reduced 2.61%	59,635 $1.45 Million
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $1.46 Million - $2.14 Million	61,235	61,235 $2.1 Million

Others Institutions Holding TBPH

# of Institutions

162

Shares Held

51.7M

Call Options Held

28.1K

Put Options Held

146K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $1.16B
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Theravance Biopharma, Inc. Transaction History